Showing 321 - 340 results of 10,616 for search 'Adweek~', query time: 3.09s Refine Results
  1. 321
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326

    Different starch sources and amino acid levels on growth performance, starch and amino acids digestion, absorption and metabolism of 0- to 3-week-old broilers fed low protein diet by Caiwei Luo, Jinping Wang, Wei Jiang, Dafei Yin, Gang Meng, Jiwei Wang, Jing Xu, Jianmin Yuan

    Published 2025-03-01
    “…The 1.32% AID Lys level and the waxy corn starch both improved the body weight (BW) of broilers from 0 to 3 weeks of age, intestinal starch digestibility, and intestinal villi height or the ratio of villi height to crypt depth (P < 0.05). …”
    Get full text
    Article
  7. 327
  8. 328
  9. 329

    Effects of a 12-Week Semi-Immersive Virtual Reality-Based Exercise Program on the Quality of Life of Older Adults Across Different Age Groups: A Randomized Controlled Trial by Li-Ting Wang, Yu-Wen Wang

    Published 2025-01-01
    “…The EG underwent a 75–90 min semi-immersive VR-based exercise intervention twice a week for 12 weeks, whereas the CG continued with their usual daily activities. …”
    Get full text
    Article
  10. 330

    A 16-week randomized controlled trial of a fish oil and whey protein-derived supplement to improve physical performance in older adults losing autonomy-A pilot study. by Anne-Julie Tessier, Julia Lévy-Ndejuru, Audrey Moyen, Marissa Lawson, Marie Lamarche, Joseé A Morais, Amritpal Bhullar, Francis Andriamampionona, Vera C Mazurak, Stéphanie Chevalier

    Published 2021-01-01
    “…<h4>Methods</h4>Participants were randomized to receive a supplement (EXP: 2g fish oil with 1500 IU vitamin D3 1x/d + 20-30g whey protein powder with 3g leucine 2x/d) or isocaloric placebo (CTR: corn oil + maltodextrin powder) for 16 weeks. Handgrip and knee extension strength (using dynamometry), physical performance tests and plasma phospholipid n-3 fatty acids (using GCMS) were evaluated at weeks 0, 8 and 16; and lean soft tissue mass (using DXA), at weeks 0 and 16.…”
    Get full text
    Article
  11. 331
  12. 332

    Minimally Invasive Fetoscopic Resection of Life-Threatening Amniotic Band Constrictions in a Human Fetus at 22 + 2 Weeks of Gestation Complicated by Subtotal Chorioamniotic Separation and Partial Placental Abruption by Nadja Riehle, Oliver Nowak, Leila Messroghli, Samantha Wakerlin, Thomas Schaible, Thomas Kohl

    Published 2024-12-01
    “…Methods: Minimally invasive, fetoscopic surgery to salvage the fetal life and lower leg was performed at 22 + 2 weeks of gestation under general maternofetal anesthesia. …”
    Get full text
    Article
  13. 333

    Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes by Noelle N. Gronroos, Caroline Swift, Monica S. Frazer, Andrew Sargent, Michael Leszko, Erin Buysman, Sara Alvarez, Tyler J. Dunn, Josh Noone

    Published 2024-11-01
    “…**Background:** Medical management of patients with type 2 diabetes mellitus (T2DM) is complex because of the chronic nature of the disease and its associated comorbidities. Injectable once-weekly semaglutide for diabetes (OW sema T2D) is a type of glucagon-like peptide–1 receptor agonist approved for the treatment of patients with T2DM. …”
    Get full text
    Article
  14. 334

    OBSERVATION OF THE NORMAL DEVELOPMENTAL PATTERN OF FETAL CEREBRAL SULCI BETWEEN 18 TO 32 WEEKS OF GESTATIONAL AGE BY USING ULTRASONOGRAPHY - A CORRELATIONAL STUDY BETWEEN TWO MATERNAL AGE GROUPS by Sujith Kumar Reddy Madithati, Sai Shankar Mankuzhy Gopalakrishnan, Santosh Chandrasekhar, Jenikar Paulraj, Archana Bala, Geeta Shankar

    Published 2022-12-01
    “…Parietooccipital fissure wass identified as dot pattern by 18-19 weeks and complete by 24 weeks. Calcarine fissure identified as dot pattern by 18 -19 weeks and almost complete by 22 weeks. …”
    Get full text
    Article
  15. 335

    Associations between use of expressed human milk at 2 weeks postpartum and human milk feeding practices to 6 months: a prospective cohort study with vulnerable women in Toronto, Canada by Cindy-Lee Dennis, Jane Francis, Alex Kiss, Deborah L O'Connor, Erica Di Ruggiero, Alison Mildon, Stacia Stewart, Bronwyn Underhill, Yi Man Ng, Christina Rousseau, Daniel W Sellen

    Published 2022-06-01
    “…Exclusions: pregnancy loss or participation in prior related study; Study B: preterm birth (&lt;34 weeks); plan to move outside Toronto; not intending to feed human milk; hospitalisation of mother or baby at 2 weeks postpartum.Primary and secondary outcome measures Main exposure variable: any use of expressed human milk at 2 weeks postpartum. …”
    Get full text
    Article
  16. 336

    Increased Fat-Free Body Mass and No Adverse Effects on Blood Lipid Concentrations 4 Weeks after Additional Meat Consumption in Comparison with an Exclusion of Meat in the Diet of Young Healthy Women by Klaus J. Petzke, Susen Lemke, Susanne Klaus

    Published 2011-01-01
    “…Women volunteered to eat low-fat meat in addition to their habitual diet (M) or to exclude meat products from their diet (NOM). After 4 weeks M and NOM were crossed over between subjects. …”
    Get full text
    Article
  17. 337

    A Comparative Study of Health Efficacy Indicators in Subjects with T2DM Applying Power Cycling to 12 Weeks of Low-Volume High-Intensity Interval Training and Moderate-Intensity Continuous Training by Jun Li, Wei Cheng, Haifeng Ma

    Published 2022-01-01
    “…The same indicators were measured after 12 weeks of intervention, and the results of the two tests within and between groups were analyzed for comparison. …”
    Get full text
    Article
  18. 338

    Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol by Sander W Tas, Joost Raaphorst, Paco M J Welsing, Jacob M van Laar, Rogier M Thurlings, Robbert J Goekoop, César Magro Checa, Jan A M van Laar, Bettina C Geertsema-Hoeve, Nicolle H Rekers, Erik Present

    Published 2025-02-01
    “…The Drug Rediscovery in IMIDs (DRIMID) consortium aims to conduct a prospective pilot basket trial to investigate the effects of filgotinib, a JAK1 preferential inhibitor approved for ulcerative colitis and rheumatoid arthritis, on disease activity, quality of life and safety in patients with refractory BD, IIM and IgG4-RD.Methods and analysis In this investigator-initiated, multicentre, open-label phase 2 study, up to 60 patients with rare IMIDs will be enrolled for a 26-week treatment period with filgotinib 200 mg once daily. …”
    Get full text
    Article
  19. 339
  20. 340

    Perinatal mortality and other severe adverse outcomes following planned birth at 39 weeks versus expectant management in low-risk women: a population based cohort studyResearch in context by Kylie Crawford, Waldemar A. Carlo, Anthony Odibo, Aris Papageorghiou, William Tarnow-Mordi, Sailesh Kumar

    Published 2025-02-01
    “…Summary: Background: Planned birth by induction of labour in low-risk, nulliparous women at 39+0–39+6 weeks gestation is associated with fewer caesarean sections, adverse maternal and neonatal outcomes and perinatal deaths compared with expectant management. …”
    Get full text
    Article